Stock Events

Stock Events

Insulet 

$154.87
130
-$2.02-1.29% Friday 20:00

Statistics

Day High
155.9
Day Low
152.28
52W High
352.82
52W Low
147.46
Volume
949,100
Avg. Volume
-
Mkt Cap
10.9B
P/E Ratio
36.27
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
0.79
1.04
1.3
1.55
Expected EPS
1.462478
Actual EPS
N/A

Financials

9.12%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
5.42BRevenue
494.2MNet Income

Analyst Ratings

249.47Average Price Target
The highest estimate is 360.00.
From 16 ratings within the last 6 months. This is not an investment recommendation.
Buy
81%
Hold
13%
Sell
6%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PODD. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Tandem Diabetes Care
TNDM
Mkt Cap1.03B
Tandem Diabetes Care, Inc. competes directly with Insulet by offering insulin pump therapy for diabetes management, which is a direct alternative to Insulet's Omnipod system.
Medtronic
MDT
Mkt Cap100.91B
Medtronic plc is a major competitor in the insulin pump market, offering a range of products that compete with Insulet's offerings for diabetes management.
Dexcom
DXCM
Mkt Cap27.82B
DexCom, Inc. provides continuous glucose monitoring (CGM) systems that are often used in conjunction with insulin pumps like those offered by Insulet, making them a competitor in the broader diabetes management space.
Abbott Laboratories
ABT
Mkt Cap152.25B
Abbott Laboratories offers the FreeStyle Libre, a CGM system that competes with the integrated diabetes management solutions provided by Insulet.
Insulet
PODD
Mkt Cap10.73B
Insulet Corporation is listed as its own competitor due to an error. Please disregard this entry.
Senseonics
SENS
Mkt Cap330.97M
Senseonics Holdings, Inc. offers the Eversense CGM system, which competes in the diabetes management market by providing an alternative to the CGM solutions that can be used with Insulet's products.
Novo Nordisk
NVO
Mkt Cap199.25B
Novo Nordisk A/S is a leading provider of insulin and other diabetes care products that, while not a direct competitor in the insulin pump market, competes in the broader diabetes management space.
Sanofi
SNY
Mkt Cap105.85B
Sanofi provides a range of diabetes care solutions, including insulin therapies that compete with the insulin management solutions offered by Insulet.
Mannkind
MNKD
Mkt Cap1.04B
MannKind Corporation offers Afrezza, an inhaled insulin, providing a non-injectable alternative to insulin delivery that competes with traditional pump therapies like those offered by Insulet.

About

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Show more...
CEO
Ms. Ashley A. McEvoy
Employees
5400
Country
United States
ISIN
US45784P1012

Listings

MI
IT
1PODD.MI
LSE
GB
0ADR.LSE
MU
DE
GOV.MU
STU
DE
GOV.STU

0 Comments

Share your thoughts

FAQ

What is Insulet stock price today?▼
The current price of PODD is $154.87 USD — it has decreased by -1.29% in the past 24 hours. Watch Insulet stock price performance more closely on the chart.
What is Insulet stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Insulet stocks are traded under the ticker PODD.
Is Insulet stock price growing?▼
PODD stock has risen by +0.17% compared to the previous week, the month change is a -18.3% fall, over the last year Insulet has showed a -51.81% decrease.
What is Insulet market cap?▼
Today Insulet has the market capitalization of 10.9B
When is the next Insulet earnings date?▼
Insulet is going to release the next earnings report on August 06, 2026.
What were Insulet earnings last quarter?▼
PODD earnings for the last quarter are 1.42 USD per share, whereas the estimation was 1.2 USD resulting in a +18.46% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Insulet revenue for the last year?▼
Insulet revenue for the last year amounts to 5.42B USD.
What is Insulet net income for the last year?▼
PODD net income for the last year is 494.2M USD.
How many employees does Insulet have?▼
As of May 26, 2026, the company has 5,400 employees.
In which sector is Insulet located?▼
Insulet operates in the Health & Wellness sector.
When did Insulet complete a stock split?▼
Insulet has not had any recent stock splits.
Where is Insulet headquartered?▼
Insulet is headquartered in Acton, United States.